CXCR3 and ovarian carcinoma: Furthermore, migration was shown to be inhibited by an anti-CXCR3 antibody in both ovarian cancer cell lines, SKOV-3 and OVCAR, as well as ovarian cancer samples derived from metastatic sites [17].